Helsinn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HELSINN, and when can generic versions of HELSINN drugs launch?
HELSINN has six approved drugs.
There are forty-three US patents protecting HELSINN drugs.
There are three hundred and seventy-three patent family members on HELSINN drugs in sixty countries and thirty-five supplementary protection certificates in fifteen countries.
Summary for Helsinn
International Patents: | 373 |
US Patents: | 43 |
Tradenames: | 4 |
Ingredients: | 5 |
NDAs: | 6 |
Patent Litigation for Helsinn: | See patent lawsuits for Helsinn |
PTAB Cases with Helsinn as patent owner: | See PTAB cases with Helsinn as patent owner |
Drugs and US Patents for Helsinn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | DISCN | Yes | No | 8,598,218*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | POWDER;INTRAVENOUS | 210493-001 | Apr 19, 2018 | DISCN | Yes | No | 10,208,073 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | DISCN | Yes | No | 9,457,020*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Helsinn Hlthcare | TRUSELTIQ | infigratinib phosphate | CAPSULE;ORAL | 214622-002 | May 28, 2021 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Helsinn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | 5,202,333 | ⤷ Try a Trial |
Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | 5,202,333 | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 9,125,905 | ⤷ Try a Trial |
Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 5,202,333*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Helsinn Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Lithuania | 2273876 | ⤷ Try a Trial |
Croatia | P20190551 | ⤷ Try a Trial |
New Zealand | 700778 | ⤷ Try a Trial |
San Marino | T201600427 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Helsinn Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2785706 | 20C1029 | France | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, EN PARTICULIER LE SEL DE CHLORHYDRATE DE CHLORURE DE FOSNETUPITANT; REGISTRATION NO/DATE: EU/1/15/1001 20200318 |
2785706 | 2090015-5 | Sweden | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT; REG. NO/DATE: EU/1/15/1001 20200317 |
2785706 | 122020000046 | Germany | ⤷ Try a Trial | PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316 |
1035115 | C01035115/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: SWISSMEDIC 65499 06.11.2015 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.